Matthew Fowler

A study showed that first-line treatment for epithelial ovarian cancer using weekly dose-dense chemotherapy did not improve progression-free survival, compared with 3-weekly chemotherapy, in European women.

Seattle Genetics announced the development after data was presented at the 2019 San Antonio Breast Cancer Symposium.

Lawrence Feldman, MD, of the division of hematology and oncology in the department of medicine at the University of Illinois at Chicago, and a team of researchers received a grant to explore addiction, abuse, and new ways to prescribe opioids.

Screening colonoscopy rates for colorectal cancer increased in low-income Latino populations when accompanied by patient navigation.